https://www.selleckchem.com/pr....oducts/l-685-458.htm
01, younger age at time of sample collection (p less then 0.001), shorter interval since transplant (p=0.09, and presence of HLA DSA (p=0.003). AT1R antibodies in stable control patients were not associated with rejection or allograft loss. However, AT1R antibodies combined with HLA DSA in patients with active allograft dysfunction were associated with rejection and allograft loss. CONCLUSIONS Our results suggest that AT1R antibodies are more common in patients with active allograft dysfunction and may be a risk factor for worse o
Like
Comment
Share
